Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, impaired memory formation, and disruption of neurocognitive functions; its hallmark neuropathological features include neural loss, neurodegeneration, amyloid-beta plaque deposition, and neurofibrillary tangles composed of hyperphosphorylated tau proteins. This evidence concerns the gene MAPT and Alzheimer disease.